Buscar
-
Repeated Piperacillin-Tazobactam Plasma Concentration Measurements in Severely Obese Versus Nonobese Critically Ill Septic Patients and The Risk of Under and Overdosing.
(Crit Care Med. vol. 45, n° 5, pp. e–470–e478, 2017-02)Article de revueLibre acceso -
Conciliation médicamenteuse et lien ville-hôpital
(Actualités pharmaceutiques. vol. 571, pp. 39–41, 2017-12)Article de revue -
Optimisation du bon usage des anticoagulants oraux directs (ACOD) via une démarche d’évaluation des pratiques professionnelles.
(Le Pharmacien Hospitalier et Clinicien. vol. 1, n° 52, pp. 51–57, 2017)Article de revue -
Intérêt du lien ville-hôpital lors de la dispensation en rétrocession de traitements innovants : exemple du Sacubitril/Valsartan.
(Le Pharmacien Hospitalier et Clinicien. vol. 2, n° 52, pp. 367–376, 2017)Article de revue -
Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion
(Journal of Critical Care. vol. 48, pp. 66–71, 2018)Article de revue -
Implementation of infliximab standardized doses after pharmacokinetic modelization in a cohort of patients with Crohn's disease.
(Digestive and Liver Disease. vol. 52, n° 4, pp. 408-413, 2020-01-01)Article de revueLibre acceso -
Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: Lessons learned from an ancillary study of the IVOIRE trial
(Journal of Translational Internal Medicine. vol. 7, n° 4, pp. 155–169, 2019-12)Article de revue -
La greffe pulmonaire et ses traitements.
(Actualités pharmaceutiques. n° 567, pp. 37–42, 2017)Article de revue -
Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When
(Journal of the American Medical Directors Association. vol. 22, n° 1, pp. 50-55.e6, 2021-01-01)Article de revueLibre acceso -
Targeting of under-75 years for the optimization of medication reconciliation with an approach based on medication risks: An observational study
(Thérapie, 2021-06-18)Article de revue